中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Recurrent gain-of-function USP8 mutations in Cushing's disease

文献类型:期刊论文

作者Ma, ZY; Song, ZJ; Chen, JH; Wang, YF; Li, SQ; Zhou, LF; Mao, Y; Li, YM; Hu, RG; Zhang, ZY
刊名CELL RESEARCH
出版日期2015
卷号25期号:3页码:306-317
关键词Cushing's disease pituitary adenomas USP8 mutation whole-exome sequencing
通讯作者Shi, YY (reprint author), Shanghai Jiao Tong Univ, Inst Social Cognit & Behav Sci, Key Lab Genet Dev & Neuropsychiat Disorders, BioX Inst,Minist Educ, Shanghai 200030, Peoples R China.,huangcx@shsmu.edu.cn ; shiyongyong@gmail.com ; zhaoyaohs@vip.sina.com
英文摘要Cushing's disease, also known as adrenocorticotropic hormone (ACTH)-secreting pituitary adenomas (PAs) that cause excess cortisol production, accounts for up to 85% of corticotrophin-dependent Cushing's syndrome cases. However, the genetic alterations in this disease are unclear. Here, we performed whole-exome sequencing of DNA derived from 12 ACTH-secreting PAs and matched blood samples, which revealed three types of somatic mutations in a candidate gene, USP8 (encoding ubiquitin-specific protease 8), exclusively in exon 14 in 8 of 12 ACTH-secreting PAs. We further evaluated somatic USP8 mutations in additional 258 PAs by Sanger sequencing. Targeted sequencing further identified a total of 17 types of USP8 variants in 67 of 108 ACTH-secreting PAs (62.04%). However, none of these mutations was detected in other types of PAs (n = 150). These mutations aggregate within the 14-3-3 binding motif of USP8 and disrupt the interaction between USP8 and 14-3-3 protein, resulting in an elevated capacity to protect EGFR from lysosomal degradation. Accordingly, PAs with mutated USP8 display a higher incidence of EGFR expression, elevated EGFR protein abundance and mRNA expression levels of POMC, which encodes the precursor of ACTH. PAs with mutated USP8 are significantly smaller in size and have higher ACTH production than wildtype PAs. In surgically resected primary USP8-mutated tumor cells, USP8 knockdown or blocking EGFR effectively attenuates ACTH secretion. Taken together, somatic gain-of-function USP8 mutations are common and contribute to ACTH overproduction in Cushing's disease. Inhibition of USP8 or EGFR is promising for treating USP8-mutated corticotrophin adenoma. Our study highlights the potentially functional mutated gene in Cushing's disease and provides insights into the therapeutics of this disease.
学科主题Cell Biology
类目[WOS]Cell Biology
关键词[WOS]GROWTH-FACTOR RECEPTOR ; SECRETING PITUITARY-ADENOMAS ; GLUCOCORTICOID RESISTANCE ; CORTICOTROPH ADENOMA ; GERMLINE AIP ; EXPRESSION ; UBPY ; GENE ; TRAFFICKING ; P27(KIP1)
收录类别SCI
语种英语
WOS记录号WOS:000350568800007
版本出版稿
源URL[http://202.127.25.143/handle/331003/37]  
专题上海生化细胞研究所_上海生科院生化细胞研究所
推荐引用方式
GB/T 7714
Ma, ZY,Song, ZJ,Chen, JH,et al. Recurrent gain-of-function USP8 mutations in Cushing's disease[J]. CELL RESEARCH,2015,25(3):306-317.
APA Ma, ZY.,Song, ZJ.,Chen, JH.,Wang, YF.,Li, SQ.,...&Zhao, Y.(2015).Recurrent gain-of-function USP8 mutations in Cushing's disease.CELL RESEARCH,25(3),306-317.
MLA Ma, ZY,et al."Recurrent gain-of-function USP8 mutations in Cushing's disease".CELL RESEARCH 25.3(2015):306-317.

入库方式: OAI收割

来源:上海生物化学与细胞生物学研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。